GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BioLargo Inc (OTCPK:BLGO) » Definitions » PS Ratio

BLGO (BioLargo) PS Ratio : 3.16 (As of Dec. 11, 2024)


View and export this data going back to 1991. Start your Free Trial

What is BioLargo PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, BioLargo's share price is $0.196. BioLargo's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.06. Hence, BioLargo's PS Ratio for today is 3.16.

Good Sign:

BioLargo Inc stock PS Ratio (=3.15) is close to 10-year low of 2.89

The historical rank and industry rank for BioLargo's PS Ratio or its related term are showing as below:

BLGO' s PS Ratio Range Over the Past 10 Years
Min: 2.89   Med: 19.17   Max: 700
Current: 3.17

During the past 13 years, BioLargo's highest PS Ratio was 700.00. The lowest was 2.89. And the median was 19.17.

BLGO's PS Ratio is ranked worse than
73.69% of 1524 companies
in the Chemicals industry
Industry Median: 1.5 vs BLGO: 3.17

BioLargo's Revenue per Sharefor the three months ended in Sep. 2024 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.06.

During the past 12 months, the average Revenue per Share Growth Rate of BioLargo was 77.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 53.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 27.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 39.00% per year.

During the past 13 years, BioLargo's highest 3-Year average Revenue per Share Growth Rate was 76.50% per year. The lowest was -89.00% per year. And the median was -3.10% per year.

Back to Basics: PS Ratio


BioLargo PS Ratio Historical Data

The historical data trend for BioLargo's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLargo PS Ratio Chart

BioLargo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.33 10.25 21.22 8.86 3.91

BioLargo Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.73 3.91 7.89 4.47 3.78

Competitive Comparison of BioLargo's PS Ratio

For the Chemicals subindustry, BioLargo's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLargo's PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BioLargo's PS Ratio distribution charts can be found below:

* The bar in red indicates where BioLargo's PS Ratio falls into.



BioLargo PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

BioLargo's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.196/0.062
=3.16

BioLargo's Share Price of today is $0.196.
BioLargo's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


BioLargo  (OTCPK:BLGO) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


BioLargo PS Ratio Related Terms

Thank you for viewing the detailed overview of BioLargo's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLargo Business Description

Traded in Other Exchanges
N/A
Address
14921 Chestnut Street, Westminster, CA, USA, 92683
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company has five segments: ONM Environmental; Clyra Medical; BLEST; BioLargo Canada and BioLargo corporate. ONM Environmental which sells odor and volatile organic control products and services, located in Westminster, California derives the maximum revenue.
Executives
Linda Park director 14921 CHESTNUT STREET, WESTMINSTER CA 92683
Christina Elaine Bray director PO BOX 234, FREDERICK CO 80530
Jack B. Strommen director 7108 31ST AVENUE N., MINNEAPOLIS MN 55427
Roberts Kent Charles Ii director 1146 OXFORD ROAD, SAN MARINO CA 91108
John S. Runyan director 30001 HILLSIDE TERRACE, SAN JUAN CAPISTRANO CA 92675
Dennis E Marshall director 3500 W. GARRY AVENUE, SANTA ANA CA 92705
Dennis P Calvert director, 10 percent owner, officer: Chief Executive Officer 3500 GARRY AVE, SANTA ANA CA 92704
New Millennium Capital Partners, Llc 10 percent owner 16333 PHOEBE AVENUE, LA MIRADA CA 90638
Charles K Dargan officer: Chief Financial Officer 8055 W. MANCHESTER AVE., SUITE 405, PLAYA DEL REY CA 90293
Joseph L Provenzano director, officer: Corporate Secretary 3500 W. GARRY AVENUE, SANTA ANA CA 92704
Iowc Technologies, Inc. 10 percent owner 2603 MAIN STREET, SUITE 1155, IRVINE CA 92614
Kenneth Reay Code 10 percent owner 16150 HERON AVENUE, LA MIRADA CA 90638
Gary Adrian Cox director 3500 W. GARRY AVENUE, SANTA ANA CA 92705
Steven V Harrison director
Eduardo Ruiz director, 10 percent owner